Directed biomolecular evolution is widely used to tailor and enhance enzymes, fluorescent proteins, and antibodies but has hitherto not been applied in the reprogramming of mammalian cells. Here, we describe a method termed directed evolution of reprogramming factors by cell selection and sequencing (DERBY-seq) to identify artificially enhanced and evolved reprogramming transcription factors. DERBY-seq entails pooled screens with libraries of positionally randomised genes, cell selection based on phenotypic readouts, and genotyping by amplicon sequencing for candidate identification. We benchmark this approach using pluripotency reprogramming with libraries based on the reprogramming factor SOX2 and the reprogramming incompetent endodermal factor SOX17. We identified several SOX2 variants outperforming the wild-type protein in three-and four-factor cocktails. The most effective variants were discovered from the SOX17 library, demonstrating that this factor can be converted into a highly potent inducer of pluripotency with a range of diverse modifications. We propose DERBY-seq as a broad-based approach to discover reprogramming factors for any donor/target cell combination applicable to direct lineage reprogramming in vitro and in vivo.
INTRODUCTION
The forcible expression of defined transcription factor (TF) cocktails can effectively engage and reprogram the epigenome of somatic cells, leading to drastic cell-fate conversions. A four-factor TF cocktail consisting of SOX2, OCT4, KLF4, and C-MYC (SOKM) directs pluripotency reprogramming in mouse and human cells (Takahashi et al., 2007; Takahashi and Yamanaka, 2006) . Alternative TF cocktails have been shown to directly interconvert somatic cell types, a process termed direct lineage reprogramming, bypassing the intermediate step of pluripotency (Graf and Enver, 2009; Tanabe et al., 2015) . However, the rate, quantity, reproducibility, and quality of cells produced by reprogramming technologies are often poor and pose challenges to translate this method for routine clinical diagnostics or cell-based therapies. For example, in pluripotency reprogramming under serum/leukemia inhibitory factor (LIF) conditions, less than 0.1% of mouse embryonic fibroblasts (MEFs) give rise to induced pluripotent stem cells (iPSCs). Only a select subset of TFs is capable of directing cell-fate conversions, and the unique molecular properties endowing them with the competence to reprogram are only poorly understood. Highly homologous TFs function differently in pluripotency reprogramming experiments. For example, if SOX17 replaces SOX2 or if OCT6 replaces OCT4, the reprogramming activity of four-factor cocktails is lost (Jauch et al., 2011; Nakagawa et al., 2008) . Intriguingly, the uniqueness of reprogramming TFs appears to rely on subtle molecular features. Rationally introduced point mutations that direct the DNA-dependent dimerization can convert SOX17 and OCT6 into pluripotency reprogramming factors, although the wild-type proteins induce endodermal or ectodermal cell lineages, respectively (Aksoy et al., 2013b; Jauch et al., 2011; Jerabek et al., 2017) . Apparently, protein engineering of endogenous factors can profoundly switch and enhance the function of reprogramming TFs. As our understanding of sequence-function relationships in transcriptional control is incomplete, rational design approaches suffer from major limitations. We therefore decided to let directed evolution take care of this problem. Directed evolution is commonly used to install new qualities to enzymes, fluorescent proteins, receptor-ligand pairs, or antibodies (Arnold, 2015) . Here we asked whether we could use the phenotypes of mammalian cells to select for artificially improved proteins. We report directed evolution of reprogramming factors by cell selection and sequencing (DERBY-seq) combining cellular reprogramming with pooled libraries, isolation of cells based on desired phenotypes, and amplicon sequencing for variant detection.
RESULTS

Design and Pooled Screening with Randomized eSOX Libraries
To benchmark DERBY-seq, we selected the reprogramming of MEFs to iPSCs as phenotypic readout. To design DERBYseq libraries, we followed two guiding principles. First, amino acids should map to structurally characterized domains with a potential to either directly influence the interactions with DNA and chromatin or to modify the association with partner factors. Second, amino acids should be conserved among orthologs but show some variability among paralogs. We reasoned that such amino acids are good candidates to confer specific functions in transcriptional control. In the case of KLF4, structures for binary protein-DNA complexes are available but the structural basis for protein-protein interactions in the context of regulatory DNA is unknown (Schuetz et al., 2011) . Thus, for KLF4 the randomization of amino acids involved in the sequence-specific base readout could be selected for library design (Figures S1A and S1B). SOX2 and OCT4 have been structurally analyzed in a number of different configurations that include heterodimeric and homodimeric complexes on different composite DNA elements (reviewed in Hou et al., 2017; Malik et al., 2018) . In consequence, structural information is available for protein-DNA as well as protein-protein contact interfaces. Sox genes possess a 79-amino-acid high-mobility group (HMG) box enabling binding to the minor groove of the DNA with sequence specificity. Besides DNA recognition, the HMG box also facilitates the interaction with protein partners in a contextdependent manner. We thus selected the structural scaffold of the HMG box to establish the DERBY-seq method. To generate artificially evolving SOX (eSOX) libraries, we selected three residues of helix 3 in the HMG box domain that are variable among the 20 paralogous SOX factors encoded in mouse or human genomes and play a role in the DNA-dependent dimerization with OCT4 (Jauch et al., 2011; Merino et al., 2014; Ng et al., 2012; Remenyi et al., 2001) (Figures 1A and 1B) . NNK sequence diversification was used to cover all 20 amino acids with 32 codons (Figure S1C ) (Packer and Liu, 2015) . In this way, we randomized E46, I53, and K57 in SOX2 and the homologous L46, V53, and E57 in SOX17 (HMG box numbering convention; Bowles et al., 2000) , leading to libraries with 20 3 = 8,000
variants excluding truncations caused by the single remaining STOP codon. Randomizing four amino acid residues would lead to substantially larger 20 4 = 160,000
variant libraries. As we aspired to probe the reprogramming activity of the whole sequence space of the eSOX libraries, we opted for the 8,000 variant libraries for our experiments.
To establish our pooled library screens, we used the reprogramming of MEFs carrying a GFP transgene controlled by regulatory sequences of Oct4 permitting the identification of pluripotent cells ( Figure 1C ). Libraries were prepared as retroviral mixtures and used to transduce MEFs in four-factor combination (4F: Oct4, Klf4, and c-Myc [OKM] + eSox) or three-factor combination (3F: Oct4 and Klf4 [OK] + eSox) under LIF/serum/vitamin C conditions (Esteban et al., 2010) ( Figures 1C, S1D , and S1E). Under these conditions, SOX2-containing cocktails can direct pluripotency reprogramming and typically yield 50-100 GFP-positive colonies per well of a 12-well plate by day 12 while the replacement of SOX2 with SOX17 impairs the capacity of 3F and 4F cocktail to generate iPSCs (Figures 2A and S1F ). However, cocktails in which SOX2 was replaced with eSOX2 or eSOX17 libraries yielded a high quantity of GFP-positive colonies, demonstrating that pooled screens with randomized factors are feasible and allow for the separation of reprogramming competent and incompetent variants (Figures 2A, 2B, S1F, and S1G) . Surprisingly, the cocktails containing randomized libraries outperformed wild-type SOX2; in particular, the library based on the otherwise inactive SOX17 shows elevated colony numbers and a higher yield of GFP-positive cells (Figures 2A, 2B , S1F, and S1G).
Identification and Selection of Variants from Pooled Screens
We next performed preparative experiments with eSOX2 and eSOX17 libraries under 3F and 4F conditions in three independent biological experiments with three technical replicates each in 6-well plates. At reprogramming days 12-14, cells were trypsinized and single-cell suspensions containing heterogeneous populations of GFP-positive and GFP-negative cells were separated by fluorescence-activated cell sorting (FACS; Figures S2A-S2C ). We observed an increased proliferation rate of cells transfected with eSOX libraries and SOX17 as compared with SOX2 ( Figure S2D ). Oct half-sites. The boxes mark sites 1, 2, and 3 and correspond to E46/I53/K57 for SOX2 and L46/V53/E57 for SOX17 subjected to randomization with NNK codons ( Figure S1C ). (B) Structural models of the SOX2-HMG/OCT4-POU dimers on canonical SoxOct DNA elements and of the SOX17-HMG/OCT4-POU dimers on compressed DNA elements. Residues mediating the DNA-dependent heterodimer formation are labeled and shown as ball-and-sticks. Structural cartoons were prepared using Chimera (https://www.cgl.ucsf.edu/chimera/). (C) Schematic representation of the DERBY-seq workflow. A pooled library of 8,000 eSOX variants was used in three biological replicates to reprogram 90,000 OG2-MEFs (30,000 MEFs plated per well of a 6-well plate) to iPSCs in LIF/serum/vitamin C medium using 3F (eSOX library plus OK) or 4F (eSOX library plus OKM) conditions. After FACS, the genomic DNA is isolated and fragments encompassing randomized codons are amplified in a two-step (eSOX17) or three-step (eSOX2) PCR procedure, and submitted for amplicon sequencing (Figures S2E and S2F) .
from the 3F eSOX2 screen also outperformed wild-type SOX2, similar to 4F candidates (Figures S2K, S2L, and S3I) . To validate the robustness of our screen, we also tested a number of variants identified in GFP-negative populations in addition to GFP-positive variants and found that the majority indeed disrupt the reprogramming activity of SOX2 ( Figures 3D and S2L ). We found that the reprogramming enhancement of candidates identified under 4F conditions is further accentuated under 3F conditions (Figures 3F and 3G) . Moreover, when introduced into equivalent positions in SOX17, NRR and AHK tripeptides convert SOX17 into a potent inducer of pluripotency ( Figure 4 ).
DERBY-Seq Identifies Variants that Convert SOX17 into a High-Performance Pluripotency Inducer
We next tested candidates derived from the library of the otherwise reprogramming incompetent SOX17 as scaffold (Figures 4A and 4B) . We selected a total of 22 (4F screen) and 17 (3F screen; Table S4 ) eSOX17 variants significantly enriched in GFP-positive cell populations for validation experiments. All of these eSOX17 variants exhibited potent pluripotency reprogramming activity ( Figures 4C-4F , S3A, and S3B). Pluripotency-promoting tripeptides derived from the eSOX17 libraries are highly diverse and include WHC (where WHC refers to a SOX17 L46W, V53H, E57C triple mutant and analogous abbreviations are used for other variants), FNV, SLQ, DYC, or HQK variants, respectively. Of note, a validation experiment revealed a number of eSOX17 variants capable of inducing pluripotency although they were enriched in GFP-negative cell populations ( Figures S3C and S3D ). Apparently, an overwhelming number of eSOX17 variants in the starting library possess the competency to induce pluripotency. This is consistent with the highly efficient pluripotency reprogramming activity of the eSOX17 starting library itself (Figures 2, S1F, and S1G). Inactive eSOX17 variants identified in 3F and 4F conditions often retained the glutamate at position 57 (the last residue of the L46V53E57 tripeptide of the SOX17 HMG box), indicating that this amino acid constitutes a major barrier blocking the pluripotency reprogramming activity of the native SOX17 protein (Figures S3E and S3F) . Conservative replacements of E57 by aspartate or glutamine could also impair reprogramming in the context of some of the tripeptides ( Figure S3F ). To further dissect the roles of the three amino acids at positions 46, 53, and 57, we selected the high-performance eSOX17 FNV variant and individually tested which of the three mutations is most critical. We found that the eSOX17 E57V mutation is necessary and sufficient to convert SOX17 into a high-performance pluripotency reprogramming factor ( Figure S3G ). Figure S4F ), and exhibited a global gene expression profile reminiscent of embryonic stem cells (ESCs) ( Figure S4G ). This indicates that artificial factor evolution does not compromise the quality of the reprogrammed cells. (Zhao et al., 2015) . Rather, eSOX2 NRR and in particular eSOX17 FNV outperform wildtype SOX2 by activating the pluripotency network faster and in a higher proportion of cells. Expression programs elicited by the reprogramming of incompetent SOX17-OKM and GFP-OKM cocktails are not identical ( Figures S5A and S6A ). In GFP-OKM conditions, cells progress to a global expression signature resembling day 3 (eSOX17 FNV and eSOX2 NRR ) or day 6 (SOX2), suggesting that this cocktail initiates reprogramming but quickly derails without activating the pluripotency network ( Figures 5B and S5A ). In SOX17-OKM conditions cells appear to enter an alternative route (Figures 5B and S5A [rightmost panel]) . Inspection of differentially expressed genes at day 9 in SOX17 and eSOX17 FNV conditions revealed that SOX17-expressing cells show an elevated expression for a number of somatic genes normally expressed in the cardiovascular system and during muscle development, including Mef2c, Tie1, Robo4, and Gfap ( Figures 5D, 5E , and S5B). This suggests that under (legend continued on next page) pluripotency reprogramming conditions SOX17 is directed to a set of target genes it would normally regulate in development, such as those required for the specification of the cardiac mesoderm (Liu et al., 2007) . We next asked how the mutations to SOX17 affect its genomic binding profile. To examine this, we performed chromatin immunoprecipitation sequencing (ChIP-seq) using antibodies for SOX17 at days 3 and 6 for SOX17-OKM and eSOX17 FNV -OKM conditions ( Figure 5A ). At both time points SOX17 and eSOX17 FNV exhibit profoundly different binding profiles and only a small fraction of sites is occupied by both factors (Figures S6B and  S6C) . De novo motif analysis using homer (http://homer. ucsd.edu/homer/motif/) revealed the canonical SoxOct DNA element as the top-scoring motif for eSOX17 FNV at days 3 and 6 ( Figure 6A ). The canonical motif consists of a CATTGTT-like Sox element juxtaposed to an ATG CAAAT-like octamer element and is found in the enhancers of many pluripotency genes (Chen et al., 2008; Knaupp et al., 2017; Whyte et al., 2013) . In SOX17 conditions, however, the preference for the canonical motif is not observed. At day 3, a single Sox element is the topscoring motif. At day 6 an alternative compressed version of a composite SoxOct element is most strongly enriched ( Figure 6A ). In the compressed SoxOct motif one base pair is eliminated, bringing the Sox and Oct half-sites closer together. We have previously found that heterodimeric binding of SOX17/OCT4 at compressed DNA elements directs the specification of the extraembryonic endoderm (Aksoy et al., 2013a) . Only SOX17, but not SOX2, can form DNA-dependent heterodimers with OCT4 on compressed DNA elements while SOX2 more effectively than SOX17 associates with OCT4 on canonical DNA elements (Jauch et al., 2011; Merino et al., 2014; Ng et al., 2012) . We next defined eSOX17 FNV -bound locations containing canonical SoxOct elements at days 3 or 6 (Figures 6B-6D ). Wild-type SOX17 is unable to target these sites. On the contrary, in particular at day 6, SOX2 and OCT4 occupy these locations (Knaupp et al., 2017) . Conversely, locations with matches to the compressed motif bound by SOX17 at days 3 or 6 are devoid of ChIP-seq signals for eSOX17 FNV , SOX2, and OCT4. This drastic change in binding profiles is illustrated by sites with canonical motifs in pluripotency super-enhancers (Whyte et al., 2013) near Klf13 and Sox2 and sites with compressed motifs near Smad2 and Id2 (Figures 6C and  6D) . We conclude that the switch in genomic binding, transcriptional regulation, and pluripotency reprogramming function of eSOX variants is tied to their enhanced targeting of pluripotency enhancers in direct partnership with OCT4.
DISCUSSION
SOX factors are versatile regulators of cellular identity. Individual SOX TFs regulate different genes in the context of different cells leading to alternative phenotypic consequences. Family members largely fulfill non-redundant roles despite strong sequence conservation in functional domains and near-identical preferences for DNA in vitro. Therefore, the functional uniqueness and context specificity are likely caused by subtle sequence variations at critical molecular interfaces that determine chromatin engagement, with profound consequences on gene expression programs and cellular fate decisions. The DERBY-seq method enables the study of sequence-function relationships of proteins regulating gene expression and mammalian cell fates, analogously to the deep mutational scanning approach pioneered in phage display assays and using yeast as functional readout (Fowler et al., 2010; Fowler and Fields, 2014) . Deep mutational scanning studies of a WW domain using phage display showed that the majority of mutations to a protein are deleterious and mitigate or destroy its capacity to bind natural ligands (Fowler et al., 2010) . Here we find that many mutations to SOX17 produce a highly potent inducer of pluripotency, although the wild-type protein is unable to direct pluripotency reprogramming. Wild-type SOX2 and SOX17 are driven to highly discordant genomic locations during the reprogramming to pluripotency (this study) as well as when forcibly expressed in mouse ESCs (Aksoy et al., 2013a ). Yet mutating specific residues in helix 3 of the HMG box of SOX17 leads to factors with a binding profile reminiscent of SOX2 during reprogramming and in pluripotent cells (eSOX17 FNV : Figure 6 or SOX17EK: Aksoy et al., 2013a) . This suggests that the inability to target pluripotency genes by counteracting heterodimer formation with Oct4 and other POU family proteins on canonical SoxOct DNA elements may be a critical step in the natural evolution of SOX17. That is, the mutations that convert SOX17 into a pluripotency reprogramming are likely deleterious for the native function of the protein. By performing a directed evolution screen in mammalian cells, we took advantage of the functional versatility of Sox genes and identified several (G) The immunofluorescence of iPSC colonies at passage 4 in 2i condition generated with eSOX17 or eSOX2 using antibodies for the pluripotency markers NANOG, SOX2, and OCT4 in comparison with iPSC colonies obtained using SOX2 wild-type controls. Scale bar, 100 mm. See also Figure S4 . (H) We propose that DERBY-seq libraries could provide a broad-based tool for lineage reprogramming for any donor-target cell combination.
artificially evolved and enhanced SOX variants (eSOX) outperforming wild-type SOX2 in three-as well as four-factor cocktails. Our findings demonstrate that native reprogramming factors are not optimally adapted to direct cell-fate conversions that do not occur during embryonic development. For cell-state changes in vitro these factors can be profoundly improved by protein design. DERBY-seq is a flexible high-throughput method allowing the robust identification of performance-improving mutations in biomoleculedriven cell-fate conversions. We anticipate that this method will provide a broadly applicable approach for enhancing mammalian cell-fate conversion including the direct lineage reprogramming in vitro and in vivo ( Figure 4H) . Upon further refinement of the randomization strategy and selection of appropriate molecular scaffolds, a single multipurpose DERBY-seq library may be sufficient to identify NRR , and eSOX17 FNV along with OKM at days 3, 6, and 9 was performed using glbase (Hutchins et al., 2014) and PC1, PC3, and PC5. Publicly available MEF, ESC, and iPSC datasets are shown as reference and marked with the GEO identifier (see Table S6 ). Trajectories are marked with dashed lines. 2D projections are shown in Figure S5A FNV compared with SOX17 conditions at day 9 of reprogramming. Genes with a log2(fold change) 2 and -log10(p-value) >20 are in red and selected genes are labeled. (E) Gene ontology analysis for differentially upregulated genes at day 9 in SOX17-OKM-expressing cells compared with eSOX17
FNV -OKM performed using metascape (http://metascape.org). (F) Bar plots for selected genes with a role in the cardiovascular system development that are elevated in the SOX17-OKM condition. In (C) and (F) the mean of duplicate RNA-seq experiments is shown. The error bars represent the range (maximum to minimum). See also Figures S5 and S6. reprogramming factors for any donor/target cell combination. The only limitation would be the ability to reliably select for cells with the desired phenotype.
EXPERIMENTAL PROCEDURES
Site Selection and Library Construction
On the basis of structural modeling and molecular dynamics simulations (Jauch et al., 2011; Merino et al., 2014; Palasingam et al., 2009) , three homologous residues of the third helix of the mouse HMG box of SOX2 and SOX17 involved in the DNA-dependent heterodimerization with POU factors were selected for comprehensive randomization mutagenesis (corresponding to HMG box residues E46/I53/K56 of SOX2 and L46/V53/E56 of SOX17). Each residue was randomized using NNK codons (where N represents A, C, G, or T and K represents G or T) resulting in a library of 20 3 = 8,000 protein variants excluding STOP codon-containing variants (see Figures  1 and S1C ). Libraries were generated using the retroviral pMX vector backbone (Kitamura et al., 2003) . Randomization and library generation was performed by GENEWIZ (Suzhou, China). One hundred microliters of the bacterial suspension containing pMX plasmids was diluted with Luria broth (LB) medium, plated on 15-cm LB/ampicillin plates, and grown for approximately 18 hr, after which the cells were harvested and cultured in 100 mL of liquid culture LB for another 18 hr. Maxiprep plasmid DNA preparations were performed with the EndoFree Maxi prep kit (Tiangen, #DP117).
Library Transfection and Virus Preparation
Plat-E cells (Morita et al., 2000) were thawed and cultured in Plat-E medium composed of DMEM (Thermo Fisher) supplemented with FNV and SOX17 ChIP-seq peak locations at day 3 and day 6 determined using Homer are shown with p values (http://homer.ucsd.edu/homer/motif/). (B) Heat maps for eSOX17 FNV , SOX17, SOX2, or OCT4 ChIP-seq signals at genomic locations bound by eSOX17 FNV containing matches to the canonical SoxOct motif (left panel) and by SOX17 containing matches to the compressed SoxOct motif (right panel) at day 3 (upper panel) day 6 (lower panel). SOX2 and OCT4 ChIP-seq data are from a study by Knaupp et al. (2017) . see also Table S6 . (C) Genome browser plots prepared using gviz (https://bioconductor.org/packages/release/bioc/html/Gviz.html) for selected locations where eSox17
FNV is bound to canonical motifs at locations annotated as pluripotency super-enhancers (Klf13, Sox2; Whyte et al., 2013) , or compressed elements bound by SOX17 near Smad2 (a location previously validated to possess enhancer activity; Aksoy et al., 2013a) or Id2.
10% fetal bovine serum (FBS; Natocor, Argentina) in 10-cm cell culture dishes for at least 36 hr without changing the medium. Cells were passaged every 2-3 days at 70%-80% confluence. Approximately 7-8 million cells per 10-cm plate were seeded 12-16 hr prior to transfection. At 70%-80% confluence, 10 mg of each pMX plasmid was used to transfect Plat-E cells with 40 mg of the transfection reagent polyethyleneimine (Polysciences, #23966) dissolved in 1 mL of Opti-MEM (Thermo Fisher Scientific, #31985070). After 12 hr the medium was changed. Virus-containing medium was collected at 48 and 72 hr after transfection and passed through 0.45-mm filters (Millipore).
Pluripotency Reprogramming
MEFs (OG2-MEF from mouse embryos collected at embryonic day 13.5 carrying a transgenic GFP reporter driven by a Oct4 promoter; Szabo et al., 2002; Yeom et al., 1996) were obtained from the GIBH animal facility. Animal care and experimental protocols were approved by the Guangzhou Institutes of Biomedicine and Health Ethical Committee. Cells were seeded at $30,000 cells per well of a 6-well plate or $15,000 cells per well of a 12-well plate, and cultured in MEF medium composed of high-glucose DMEM containing 4.5 g/L D-glucose supplemented with 10% FBS (Natocor, #SFBE), 13 GlutaMAX (Thermo Fisher Scientific, #35050061), 13 nonessential amino acids (NEAA; Thermo Fisher Scientific, #11140050) and 0.53 penicillin/streptomycin (Hyclone, #SV30010) for 8-10 hr prior to viral transduction. One milliliter of filtered retroviral supernatant containing polybrene at a concentration of 8 mg/mL (Sigma-Aldrich, #40804ES76) of each factor (OSKM) was added twice in a 24-hr interval. After 48 hr of viral infection, MEF medium was replaced with mES medium (high-glucose DMEM containing 4.5 g/L D-glucose supplemented with 15% FBS, 1% NEAA, 1% GlutaMAX, 1% sodium pyruvate, 0.5% penicillin/streptomycin, 1,000 U/mL LIF, 0.055 mM b-mercaptoethanol, and 50 mg/mL vitamin C; Esteban et al., 2010) . The day of media change is considered as reprogramming day 0. The reprogramming cells were maintained at 37 C and 5% CO 2 (BB15 incubator; Thermo Fisher Scientific) and monitored using a phase-contrast microscope (Zeiss Axio Vert.A1). Every 24 hr mES medium was changed. For whole-well scanning the medium was removed and 13 Dulbecco's PBS (DPBS; Thermo Fisher Scientific, #14190144) was added (at day 10 for 4F and day 12 for 3F eSOX2 variants, and at day 10 for eSOX17 variants), and whole-well scans were taken from 12-well plates using an ImageXpress Micro XLS confocal High-Content Analysis System (Molecular Devices).
Fluorescence-Activated Cell Sorting
To separate reprogramming from non-reprogramming populations in pooled library screens we performed FACS, whereby OG2-MEFs were reprogrammed in 6-well tissue culture plates for 12-15 days, mES medium was removed, and cells were washed twice with 13 DPBS. The cells in each well were then dissociated with 1 mL of 0.25% trypsin/1 mM EDTA (Thermo Fisher Scientific, #25300054), passed through a 40-mm BD cell strainer, and diluted in FACS buffer (13 DPBS + 2 mM EDTA + 0.1% BSA) to 6-7 million cells/mL. For each sample, cells from three replicate wells were combined in one tube and used for two-way cell sorting. Cells were sorted by using the 488-nm GFP laser channel of a Beckman
Coulter-MoFlo Astrios. Approximately, 20,000-100,000 GFP-positive and GFP-negative cells were collected for each sample. To compare eSOX variants, we performed analytical cell sorting using a BD Accuri C6 device with FlowJo 7.6 software analyzing $30,000 life cells per variant. FACS plots used to calibrate gating are shown in Figures 2B and S1G (lower panel) (BD Accuri) and Figure S2A (MoFlo).
Next-Generation Library Preparation and Sequencing
Genomic DNA was isolated from GFP-positive and GFP-negative cells using a Quick gDNA micro prep kit (Zymo Research, #D3020). As a control, gDNA was also extracted from unsorted, transduced cells 60 hr after transfection (for the eSOX17 library only). As a further control, the Maxiprepped library in the pMX backbone was sequenced for both eSOX libraries. For the eSOX2 input library control, the plasmid library was serially diluted prior to the PCR starting from 5.68 10 to 5.68 6 molecules ( Figure S2E ). For the eSOX17 experiment, the plasmid library was diluted to 1 million molecules per PCR reaction ($0.625 pg). Amplicon libraries were produced in a three-step (eSOX2 library) or two-step (eSOX17 library) PCR scheme ( Figures S2E and S2F) . First, pMX transgenes were amplified by a 15-cycle PCR using DreamTaq Green PCR Master Mix (Thermo Fisher Scientific, #K1082) and products were purified using a PCR purification kit (Tiangen, #DP209). Second, a 6-cycle PCR was performed with primers flanking the randomized portion and overhangs encoding barcodes and parts of the adapters required for Illumina sequencing (Table S1 ). Third, in a last 6-cycle PCR, the remainder of the Illumina adapters was added. The resulting $250-bp PCR products were electrophoresed and purified using a Midi Gel Purification kit (Tiangen, #DP209). In the case of the eSOX17 library, the exon-intron gene structure allows for the discrimination of endogenous and exogenous Sox17 and primers flanking the randomized portion and overhangs with adapters were used in the first 15-cycle PCR reaction. In the second 12-cycle PCR, the full barcoded Illumina adapters were added. Samples were quantified with a Qubit (Thermo Fisher Scientific) and 50 ng of DNA was submitted to WuxiApptech for sequencing with an Illumina HiSeq 2500 with cluster generation (concentration 8 pM 2 ) by using 125-bp pairedend reads. The sample was run using Illumina standard procedures, with 15% genomic PhiX DNA (Illumina) added to increase sequence diversity. Primer sequences used to extract exogenous genes and Illumina adaptors with barcodes used for multiplexing are listed in Table S1 .
Colony Picking and Passaging
iPSC colonies with compact dome-shaped morphology were picked between days 10 and 12 using a sterile glass rod and micropipette and transferred into a 1.5-mL tube containing $30 mL of 0.25% trypsin/EDTA. The cells were then incubated for 3-5 min and seeded on feeder MEFs treated with mitomycin C and grown for 4-5 days in mES medium. Colonies were selected and picked based on dome-shaped morphology and bright GFP fluorescence and seeded on gelatin-coated 24-well plates. From passage 2 onward the cells were maintained in feeder-free conditions in chemically defined 2i medium (Ying et al., 2008 Karyotyping iPSCs were cultured on 6-cm plates in 2i medium. At 70% confluence, demecolcine (Aladdin, #477305) was added to a concentration of 20 mg/mL. After 1 hr cells were trypsinized, collected by centrifugation at 200 3 g for 3 min, resuspended in 8 mL of 0.075 M KCl, and incubated at 37 C for 20 min. Two milliliters of fixative solution (acetic acid [Merck Millipore, #100062] and methanol [Merck Millipore, #822283] at 1:3) were added, mixed gently, and incubated at 37 C for 10 min. The supernatant was removed by centrifugation and the pre-cooled fixative solution was added to 10 mL. Cells were distributed on a cold cover slide and incubated at 75 C for 3 hr. After trypsin treatment and Giemsa staining (Sigma-Aldrich, #48900), metaphase spreads were analyzed on a microscope (Olympus BX51).
Immunofluorescence
After 4-5 passages, the iPSCs were counted and 1-2 million cells were seeded on 24-well cell culture dishes pre-coated with 0.1% gelatin, and grown for 24-48 hr in 2i medium until 80% confluence. Cells were washed three times with DPBS (13) and fixed with 4% paraformaldehyde at room temperature for 15 min. Cells were permeabilized by incubation with 0.2% Triton X-100 (Sigma-Aldrich, #T8787) and dissolved in 10% BSA (MPBIO, #0218054991) in 13 DPBS at room temperature for 30 min. Afterward, the permeabilized cells were washed twice with 13 DPBS and incubated with primary antibodies for NANOG (Novus, #NB100-58842, 1:500), OCT4 (Santa Cruz Biotechnology, #sc-5279, 1:500) and SOX2 (Santa Cruz; #sc-17320, 1:500) at 4 C overnight.
The cells were then washed three times for 5 min with DPBS (13) and incubated with secondary antibodies required for the respective primary antibody (donkey-anti-rabbit: Thermo Fisher Scientific #A24870, 1:250; rabbit-anti-mouse: Thermo Fisher Scientific #A21063, 1:500; donkey-anti-goat: Abcam #ab6949, 1:500) in darkness at room temperature for 2 hr. Cells were washed three times with DPBS (13) for 5 min. The cells were further stained with 13 DAPI (Thermo Fisher Scientific, #R37606) and imaged with an Axio Vert.A1 (Zeiss).
mRNA Isolation and Real-Time qPCR
The iPSCs after 4-5 passages were cultured in 6-well plates and at 80% confluence the medium was removed, cells were washed with DPBS, and the RNA was extracted using the TRIzol method. Total RNA was purified using the PureLink RNA MiniKit (Ambion, #12183025) and quantified using a Nanodrop spectrophotometer. Five micrograms of total mRNA was used to synthesize the cDNA with a ReverTra Ace qPCR RT master mix (Toybo FSQ201s) . qPCR was performed with iTaq Universal SYBR Green Supermix on a CFX-96 thermocycler (Bio-Rad). Samples were run in technical triplicates. Relative gene expression was calculated using the 2 ÀDDCt method (Livak and Schmittgen, 2001 ) with Actin as endogenous control and the MEFs of 5-day samples as calibrator. Primers are listed in Table S5 .
Estimation of Cell Proliferation
OG2 MEF cells were transduced with retroviral supernatant and at reprogramming day 1 cells were trypsinized. The cells from singlecell suspension were counted using a Scepter 2.0 cell counter (Millipore), and 10,000 cells were seeded on 12-well cell culture plates and cultured for 48 hr in mES medium before being counted again.
Processing of Amplicon Sequencing Data
Reads were de-multiplexed using the raw fastq files and a custom Python script. The data were further analyzed using the R (https:// www.rstudio.com/), BioStrings (https://bioconductor.org/packages/ release/bioc/html/Biostrings.html), and data.table (https://cran. r-project.org/web/packages/data.table/index.html) packages. First, relevant positions of randomized codons were extracted and translated, and trip-peptides were counted to construct count matrices where rows are variants and columns replicate GFP-positive and -negative conditions. DESeq2 (Love et al., 2014) was used to score the differential enrichment of variants in GFP-positive or -negative cell populations by pairing biological replicates (as in Tables S2 and  S3 ). Candidates were selected for validation experiments from volcano plots where log 2 fold change and adjusted p-value scores are taken into account using data from 3F to 4F conditions. Biophysical properties of amino acids were also considered in order to test diverse candidates (i.e., charge, size, hydrophobicity).
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All raw and processed data reported here from DERBY-seq, RNA-seq, and ChIP-seq have been deposited to NCBI GEO under accession number GEO: GSE107987. The Python scripts use to de-multiplex the reads and the R codes used to perform the DERBY-seq analysis are available on request from the authors. 
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